Anteris Technologies Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AMEUF research report →
About the company
Anteris Technologies Ltd. is a medical device company focused on structural heart solutions. The firm manufactures and commercializes ADAPT, an advanced regenerative tissue product.
- CEO
- Wayne Geoffrey Paterson
- IPO
- 2013
- HQ
- Toowong, QLD, AU
Price Chart
- Market Cap
- $120.50M
- P/E
- -4.25
- P/S
- 221.93
- P/B
- -3976.48
- EV/EBITDA
- -4.30
- Div Yield
- 0.00%
- Gross Margin
- 69.53%
- Op Margin
- -5099.87%
- Net Margin
- -5115.59%
- ROE
- -715.34%
- ROIC
- -3929.86%
- Revenue
- $4.37M · 8.83%
- Net Income
- $-123,263,368 · -83.06%
- EPS
- $-6.09 · -41.30%
- Op Income
- $-126,625,640
- FCF YoY
- -86.58%
- 52W High
- $15.53
- 52W Low
- $5.55
- 50D MA
- $7.00
- 200D MA
- $10.64
- Beta
- 0.75
- Avg Volume
- 2.18K
Get TickerSpark's AI analysis on AMEUF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our AMEUF coverage
Recent articles, reports, and earnings notes.
No research on AMEUF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AMEUF report →Similar companies
Peers in the same neighborhood.